MiMedx Group, Inc. (MDXG)
NASDAQ: MDXG · Real-Time Price · USD
7.17
-0.08 (-1.10%)
May 13, 2025, 1:14 PM - Market open
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Hospital | 187.44M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Hospital Growth | 0.24% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Private Office | 112.39M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Private Office Growth | 17.33% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 49.05M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 26.79% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Wound & Surgical | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Corporate & Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Tissue/Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cord | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Section 351 | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Regenerative Biomaterials | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Regenerative Biomaterials Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| United States | 348.88M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 8.52% |
Log In |
Log In |
Log In |
Log In | Upgrade
|